Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia

Phase 4CompletedNCT01191476

Abbott336 enrolled

Overview

This study is being performed to compare the cost of anesthetic techniques with sevoflurane (low fresh gas flow balanced anesthesia) versus propofol (target controlled infusion \[TCI\]) versus propofol induction and sevoflurane maintenance anesthesia in subjects undergoing elective laparoscopic surgery with predicted anesthesic use between 1 and 3 hour duration.

Three hundred thirty-six subjects were enrolled in this study. Two subjects, one treated with propofol for induction and maintenance and one treated with propofol for induction and sevoflurane for maintenance are not included in the study participation since no information was available for these two subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

336

Conditions

Elective Laparoscopic Surgery

Interventions

Propofol Target Controlled Infusion for Induction and Sevoflurane Inhalation for MaintenanceDRUG

Propofol was administered as a bolus IV dose of 1.5 mg/kg for induction at a rate of 40 mg/10 seconds. During maintenance, a sevoflurane concentration of 0.8-1.5 minimal alveolar concentration (MAC) was administered at a rate of 1 L/min fresh gas flow.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria 1. Men or women, aged from 18 to 65 2. ASA (American Society of Anesthesiologists) physical status (a requirement of the subject's physical status): I or II 3. Body mass index (weight/height\^2) from 16 to 30 kg/m\^2 4. Elective laparoscopic surgery requiring general anesthesia managed with endotracheal intubation 5. Duration of anesthesia use will be greater than or equal to 1 hour, but less than 3 hours in length. Exclusion Criteria 1. Hypersensitivity or unusual response to any halogenated anesthetics. 2. History of significant cardiovascular, pulmonary, hepatic, renal, central nervous system or muscular disease. 3. Pre-operative cognitive dysfunction or disabling neuropsychiatric disorders. 4. Need for emergency surgery or surgery requiring additional regional anesthetic techniques. 5. Need for intracranial surgery, cardio-surgery or thoracic surgery. 6. Subjects inability to cooperate with the anesthetist before administration of the anesthetic agent. 7. Personal or familial history of malignant hyperthermia. 8. Females who are either pregnant or breast feeding.

Locations (4)

Site Reference ID/Investigator# 41983

Beijing, China

Site Reference ID/Investigator# 41932

Chengdu, China

Site Reference ID/Investigator# 41985

Guangzhou, China

Site Reference ID/Investigator# 41984

Shanghai, China

Outcomes

Primary Outcomes

Cost of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoflurane, Total Intravenous Anesthesia (TIVA) With Propofol, or Intravenous Induction With Propofol and Inhalational Maintenance With Sevoflurane

\[Cost of VIMA = unit price of sevoflurane X used volume of sevoflurane\]; \[Cost of TIVA = unit price of propofol X total volume of propofol in the syringe\]; \[Cost of Propofol Induction and Sevoflurane Maintenance = unit price of propofol X total volume of propofol in the syringe + unit price of sevoflurane X volume of sevoflurane in the syringe\]. The total volume of propofol in the syringe was calculated, even if all the anesthetic was not used, because it could not be reused.

Time frame: Anesthetic Duration between 1 to 3 Hours

Secondary Outcomes

Time to Loss of Consciousness

Loss of consciousness was measured from the time the anesthetic was administered until loss of consciousness (no response to command) occurred. Inhalational induction was induced with sevoflurane via vital capacity induction at 8%. Intravenous induction was induced with propofol at 4 µg/mL via target controlled infusion (TCI). In subjects who received both anesthetic agents, a bolus dose of propofol 1.5 mg/kg was used for induction.

Time frame: Up to 10 minutes

Time to Eye Opening

Measured from the time sevoflurane or propofol administration was stopped until the subject's eyes were opened. The investigator tapped the subject on the forehead or shoulder after anesthesia was stopped and asked them to open their eyes. This process was repeated approximately every minute until eye opening occurred.

Time frame: Every minute after anesthesia was stopped until the subjects' eyes opened

Time to Extubation

Time to extubation was measured from the time sevoflurane or propofol administration was stopped until tracheal extubation occurred. Criteria to determine extubation included a train of four stimulus \> 0.9 (a method to measure the magnitude and type of neuromuscular block, a ratio of the fourth response to the first one), a tidal volume \> 5 mL/kg, minute ventilation \> 3 L, a respiratory rate of \> 10 breaths/minute, an end tidal carbon dioxide \< 45 mmHg, and eye opening has occurred.

Time frame: Every minute after anesthesia was stopped until extubation occurred

Time to Orientation

Time to orientation was measured from the time sevoflurane or propofol administration was stopped until orientation (able to state their name and date of birth).

Time frame: Every minute after anesthesia was stopped until orientation occurred